Cystic Fibrosis Trust

Cystic Fibrosis Trust
Name	Cystic Fibrosis Trust
Type	Charity
Founded	1964
Headquarters	London, United Kingdom
Region served	United Kingdom
Focus	Health, Research, Patient support

Cystic Fibrosis Trust The Cystic Fibrosis Trust is a British charity formed to fund research, provide patient services and campaign for people affected by cystic fibrosis. It operates across the United Kingdom, engaging with institutions and stakeholders to influence health policy and clinical practice. The Trust collaborates with research centres, hospitals and international organizations to accelerate therapeutic development and improve standards of care.

History

The organization was established in 1964 amid rising public attention to genetic disorders and pediatric care, contemporaneous with initiatives led by figures associated with NHS reforms and medical charities such as Wellcome Trust and British Medical Association. Early decades saw partnership with academic centres like University of Cambridge and University of Oxford for basic science, while later periods involved engagement with regulatory bodies including Medicines and Healthcare products Regulatory Agency and funding agencies such as Medical Research Council. Milestones include support for clinical trials at specialist units in Great Ormond Street Hospital and policy influence during debates in the Parliament of the United Kingdom over orphan drug access and rare disease strategy.

Organization and Governance

Governance follows charity law frameworks overseen by trustees drawn from clinical, academic and philanthropic backgrounds, akin to board structures at British Heart Foundation and Cancer Research UK. Executive leadership interacts with clinical networks in NHS Trusts like Guy's and St Thomas' NHS Foundation Trust and commissioning bodies formerly associated with Clinical Commissioning Groups (CCGs). Corporate compliance and fundraising stewardship are influenced by standards set by the Charity Commission for England and Wales and comparative governance at institutions such as National Institute for Health and Care Excellence.

Funding and Campaigns

The Trust raises funds through public appeals, corporate partnerships and legacy giving, following models seen at Macmillan Cancer Support and Marie Curie. High-profile campaigns have targeted drug pricing and access analogous to efforts by Patients Association and advocacy groups like Royal College of Physicians. Fundraising events have included collaborations with cultural institutions such as Royal Albert Hall and sports organisations including Football Association clubs to increase visibility and support.

Research and Grants

Research funding priorities include gene therapy, modulators and infection control, with grants awarded to laboratories at University College London, Imperial College London and international centres such as Harvard Medical School and Stanford University. The Trust has co-funded clinical trials alongside pharmaceutical companies and consortia similar to collaborations with GlaxoSmithKline and Vertex Pharmaceuticals while engaging regulatory science exemplified by interactions with European Medicines Agency and health technology assessment bodies like National Institute for Health and Care Excellence. Training fellowships and PhD support reflect partnerships with funders such as Wellcome Trust and Biotechnology and Biological Sciences Research Council.

Patient Support and Services

Services encompass information provision, care coordination and psychosocial support, delivered in conjunction with specialist centres at Royal Brompton Hospital and paediatric units at Alder Hey Children's Hospital. Support lines and resources mirror service models used by Samaritans and Mind (charity), while educational materials are developed for multidisciplinary teams including physiotherapists and dietitians affiliated with professional bodies like Chartered Society of Physiotherapy and Royal College of Paediatrics and Child Health. Residential and respite provisions have been promoted in partnership with local authorities and trusts across regions such as Greater London and West Midlands.

Advocacy and Policy

Advocacy work has targeted drug approval pathways, newborn screening and care standards, engaging policymakers in the Cabinet Office and committees of the House of Commons Health Select Committee. Campaigns to secure access to modulators and rare disease funding have involved legal and policy dialogue with entities like NHS England and international advocacy groups including European Cystic Fibrosis Society. The Trust has contributed to consultations led by National Institute for Health and Care Excellence and participated in cross-sector alliances addressing orphan medicinal products legislation in the European Union context.

Partnerships and Collaborations

Collaborations span academia, industry and health services, including projects with universities such as University of Edinburgh and industrial partners comparable to AstraZeneca and Pfizer. International links extend to organisations like World Health Organization and research networks such as European Respiratory Society, while joint initiatives with patient organisations have paralleled alliances with Genetic Alliance UK and rare disease coalitions. These partnerships support translational medicine pipelines, registry development and data-sharing efforts aligned with standards from bodies like Health Data Research UK.

Category:Health charities based in the United Kingdom